Nine Home Runs and a New Set of Eyes: Why the Blue Jays' 2027 Rests on Vlad Jr.'s Vision

The most consequential Blue Jays news of the last week didn't come from a game — Toronto's season ended at 79-83, last place in the AL East, one year after a 104-win run to the World Series. It came from an Instagram post by the Laser Eye Center of Miami, confirmed by Sportsnet's Ben Nicholson-Smith: Vladimir Guerrero Jr. underwent laser eye surgery.

That's the entire offseason in one sentence for a franchise that just watched its $500 million first baseman post the worst year of his career.

The fall, by the numbers

Guerrero hit .260/.332/.356 with nine home runs and 57 RBI in 144 games — a .688 OPS that sits 160 points below the .848 he posted in 2025 and 252 below the .940 of 2024. His wRC+ tumbled from an average of 139 across 2023-25 to 95, and his WAR came in at roughly 1.0. For a player whose value was supposed to anchor the lineup through the next decade, that's a crater, not a dip.

The underlying metrics say the collapse wasn't purely bad luck, but they also don't say he's finished. His expected batting average (.280) and expected slugging (.400) both ran ahead of his actual results, and he still graded in the 92nd percentile in bat speed and 98th in max exit velocity. The power outage has a shape, though: a 6.9% barrel rate (40th percentile), a 24th-percentile xISO, and an average launch angle of 8.3 degrees — a ground-ball tilt on a frame that should be launching baseballs.

Most damning is the pitch-type split. Guerrero hit .136 with a .148 slugging percentage against sliders and .080 with a .140 slugging percentage against cutters, combining for minus-15 run value on those two offerings alone. He punished fastballs (.342) and sinkers (.331). Breaking balls ate him alive.

Does vision explain it?

Here's where caution is required. Multiple outlets have framed the surgery as a possible root cause — and it's a tidy narrative for a hitter who suddenly couldn't identify spin. But the timeline is unclear (the clinic's post came during a post-op visit), and no one has publicly confirmed Guerrero's vision was compromised during the season. He also dealt with left lower back tightness in September, exiting a game in Texas early. Attributing a 95 wRC+ to his corneas is a leap, even a plausible one.

What's not debatable is the stakes. Guerrero already spent September apologizing for comments defending his $500 million deal as payment for past performance — a remark his Hall of Fame father reportedly told him was wrong. GM Ross Atkins and president Mark Shapiro have both publicly expressed confidence in a 2027 rebound.

The bigger picture in Toronto

Guerrero's revival isn't the only item on the list. The injured list tells the season's story: José Berríos, Anthony Santander, Addison Barger, Yimi García, Bowden Francis and Patrick Corbin all finished on the 60-day IL, ten names deep. The pitching staff held up anyway — a 3.87 team ERA, 10th in baseball, and a bullpen at 2.57 — while the offense sank to a .692 OPS with 138 home runs. That imbalance is why Toronto scored 648 runs and allowed 694.

The offseason question isn't whether the Blue Jays need a bat. It's whether they already have one. A healthy, clear-eyed Guerrero returning to something near his 2025 form would repair the lineup's center of gravity without a single transaction. Another year at a 95 wRC+, and no amount of rotation depth will matter.

The surgery itself shouldn't affect his offseason. Whether it affects his season is the most important unknown in Toronto.